Medicare Enrolled
Dr. Rajiv Malik, M.D.
Hematology & Oncology · San Bernardino, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Malik from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Malik?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Malik
Dr. Rajiv Malik is a hematology & oncology specialist in San Bernardino, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Malik performed 29,690 Medicare services across 1,305 unique beneficiaries.
Between the years covered by Open Payments, Dr. Malik received a total of $19,798 from 90 pharmaceutical and/or device companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Malik is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 20% volume in CA
$19,798 industry payments
Medicare Practice Summary
Medicare Utilization ↗29,690
Medicare services
Top 20% in CA for hematology & oncology
1,305
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,484 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 6,600 | $18 | $40 |
| Paclitaxel chemotherapy injection | 5,170 | $0 | $1 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,095 | $0 | $3 |
| Injection, granisetron hydrochloride, 100 mcg | 3,350 | $0 | $3 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
3,200 | $6 | $18 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
1,600 | $6 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
970 | $95 | $140 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
689 | $8 | $15 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
528 | $24 | $60 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
494 | $53 | $105 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
399 | $6 | $7 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
323 | $109 | $269 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
291 | $11 | $35 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
173 | $1 | $3 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
147 | $54 | $120 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
114 | $7 | $15 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
105 | $64 | $95 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
89 | $24 | $60 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
77 | $27 | $89 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
67 | $27 | $45 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
64 | $1 | $5 |
| New patient office visit, complex (60-74 min) | 51 | $153 | $260 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
50 | $10 | $40 |
| Heparin sodium injection, per 1000 units An injection of heparin sodium, a blood thinner, administered in units of 1000. |
44 | $0 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.3% high complexity
87.1% medium
7.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$19,798
Total received (2018-2024)
Avg $2,828/year across 7 years
Top 21% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
90
Companies
981
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,474 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$324 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,136
2023
$2,613
2022
$2,973
2021
$2,848
2020
$2,213
2019
$2,944
2018
$3,071
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$295
PFIZER INC.
$271
E.R. Squibb & Sons, L.L.C.
$224
AstraZeneca Pharmaceuticals LP
$211
Merck Sharp & Dohme LLC
$200
ABBVIE INC.
$159
Janssen Biotech, Inc.
$148
Eisai Inc.
$141
CSL Behring
$110
Tempus AI, Inc
$93
Lilly USA, LLC
$91
EAGLE PHARMACEUTICALS, INC.
$89
GlaxoSmithKline, LLC.
$87
BeiGene USA, Inc.
$77
Alexion Pharmaceuticals, Inc.
$61
SOBI, INC
$59
SpringWorks Therapeutics, Inc.
$55
Daiichi Sankyo Inc.
$52
Gilead Sciences, Inc.
$49
Genentech USA, Inc.
$48
PUMA BIOTECHNOLOGY, INC.
$48
Regeneron Healthcare Solutions, Inc.
$47
ARRAY BIOPHARMA INC
$40
SERVIER PHARMACEUTICALS LLC
$38
Immunocore Limited
$38
TAIHO ONCOLOGY, INC.
$38
Rigel Pharmaceuticals, Inc.
$35
Aveo Pharmaceuticals, Inc.
$32
Takeda Pharmaceuticals U.S.A., Inc.
$32
EMD Serono, Inc.
$30
Genmab U.S., Inc.
$29
Incyte Corporation
$28
Karyopharm Therapeutics Inc.
$25
Agios Pharmaceuticals, Inc.
$23
Celgene Corporation
$21
Exelixis Inc.
$20
RECORDATI_RARE_DISEASES_INC.
$20
ADC Therapeutics America, Inc.
$20
Adaptive Biotechnologies Corporation
$19
GENZYME CORPORATION
$18
Emmaus Medical, Inc.
$16
Top 3 companies account for 25.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,711
Janssen Biotech, Inc.
$1,263
E.R. Squibb & Sons, L.L.C.
$1,262
AstraZeneca Pharmaceuticals LP
$1,035
Amgen Inc.
$870
PFIZER INC.
$860
Merck Sharp & Dohme Corporation
$825
GENZYME CORPORATION
$737
Genentech USA, Inc.
$716
BeiGene USA, Inc.
$545
Incyte Corporation
$525
Celgene Corporation
$496
Seagen Inc.
$494
Merck Sharp & Dohme LLC
$493
GlaxoSmithKline, LLC.
$482
Astellas Pharma US Inc
$467
CSL Behring
$403
Takeda Pharmaceuticals U.S.A., Inc.
$368
Eisai Inc.
$322
Gilead Sciences, Inc.
$320
Pharmacyclics LLC, An AbbVie Company
$295
Daiichi Sankyo Inc.
$267
Alexion Pharmaceuticals, Inc.
$234
Lilly USA, LLC
$231
Bayer HealthCare Pharmaceuticals Inc.
$209
Karyopharm Therapeutics Inc.
$193
Rigel Pharmaceuticals, Inc.
$188
Puma Biotechnology, Inc.
$185
ABBVIE INC.
$182
Teva Pharmaceuticals USA, Inc.
$170
Regeneron Healthcare Solutions, Inc.
$154
SOBI, INC
$148
Boehringer Ingelheim Pharmaceuticals, Inc.
$142
EMD Serono, Inc.
$133
Kite Pharma, Inc.
$131
PUMA BIOTECHNOLOGY, INC.
$127
Dova Pharmaceuticals
$127
ZOLL Respicardia, Inc.
$119
Exelixis Inc.
$109
Foundation Medicine, Inc.
$107
EISAI INC.
$97
Tempus AI, Inc
$93
EAGLE PHARMACEUTICALS, INC.
$89
Kyowa Kirin, Inc.
$81
Epizyme, Inc.,
$79
EUSA Pharma (US) LLC
$79
Acrotech Biopharma LLC
$75
TOLMAR Pharmaceuticals, Inc.
$73
Ipsen Biopharmaceuticals, Inc
$70
Taiho Oncology, Inc.
$68
AVEO Pharmaceuticals, Inc.
$65
Sumitomo Pharma America, Inc.
$62
Spectrum Pharmaceuticals Inc.
$60
AbbVie, Inc.
$59
ARRAY BIOPHARMA INC
$55
TAIHO ONCOLOGY, INC.
$55
SpringWorks Therapeutics, Inc.
$55
Bayer Healthcare Pharmaceuticals Inc.
$54
Pharmacyclics LLC, an AbbVie Company
$52
TESARO, Inc.
$52
Aurobindo Pharma USA, Inc.
$50
AMAG Pharmaceuticals, Inc.
$44
MorphoSys, US Inc.
$42
Deciphera Pharmaceuticals Inc.
$42
SERVIER PHARMACEUTICALS LLC
$38
Immunocore Limited
$38
Seattle Genetics, Inc.
$37
Array BioPharma Inc.
$36
Aveo Pharmaceuticals, Inc.
$32
INSYS Therapeutics Inc
$30
Genmab U.S., Inc.
$29
Janssen Scientific Affairs, LLC
$28
CTI BioPharma Corp.
$25
Pharmacosmos Therapeutics Inc.
$24
Verastem, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$23
Agios Pharmaceuticals, Inc.
$23
RECORDATI_RARE_DISEASES_INC.
$20
ADC Therapeutics America, Inc.
$20
Immunomedics, Inc.
$19
Adaptive Biotechnologies Corporation
$19
Global Blood Therapeutics, Inc.
$17
Otsuka America Pharmaceutical, Inc.
$17
Horizon Therapeutics plc
$17
Dendreon Pharmaceuticals LLC
$17
Emmaus Medical, Inc.
$16
JAZZ PHARMACEUTICALS INC.
$15
Janssen Pharmaceuticals, Inc
$14
Helsinn Therapeutics (U.S.), Inc.
$13
Secura Bio, Inc.
$11
Top 3 companies account for 21.4% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · Abraxane · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BENDEKA · BLENREP · BOSULIF · BRUKINSA · Balversa · Bavencio · Beleodaq · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CYRAMZA · Cabometyx · Copiktra · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELIGARD · ELITEK · ELOCTATE · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Endari · Enhertu · Epkinly · Erleada · FARESTON · FASLODEX · FERAHEME · FOLOTYN · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Farydak · Folotyn · GAZYVA · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRYSTEXXA · Kyprolis · LENVIMA · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · PADCEV · PEMAZYRE · PEMFEXY · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Padcev · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RYDAPT · Revlimid · Rezlidhia · SANDOSTATIN · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYLVANT · SYNDROS · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Vectibix · Venclexta · Vonjo · Voranigo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XTANDI · XYNTHA · Xofigo · Xospata · ZEJULA · ZEPZELCA · ZYTIGA · clonoSEQ · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
42
Per 100K population
1.9
County median income
$82,184
Nearest hospital
ST BERNARDINE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Malik is a mixed practice specialist, with above-average Medicare volume (top 20% in CA), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Malik experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Malik performed 6,600 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Malik receive payments from pharmaceutical companies?
Yes. Dr. Malik received a total of $19,798 from 90 companies across 981 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Malik's costs compare to other hematology & oncology specialists in San Bernardino?
Dr. Malik's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Malik) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in San Bernardino
Browse hematology & oncology specialists in San Bernardino ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology